Nextech Invest Ltd's Q1 2022 13F: 3 new positions

Form 13F-HR for the quarter ended Mar 31, 2022 · filed May 16, 2022 · 14 reported positions · accession 0001104659-22-060901

What changed this quarter

Nextech Invest Ltd's changes in reported equity positions, Q1 2022
Activity Security Weight before Weight now Change Shares Shares %
Increased REVOLUTION MEDICINES INC (RVMD) 19.7% 28.7% +9.0 pts +971K sh +33%
New MIRATI THERAPEUTICS INC (MRTX) — 4.1% +4.1 pts +173K sh new
New RELAY THERAPEUTICS INC (RLAY) — 4.1% +4.1 pts +475K sh new
New BLUEPRINT MEDICINES CORP (BPMC) — 3.4% +3.4 pts +188K sh new

Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled

Top 10 positions — 90.5% of the equity book

Changes in the top 10 this quarter: MRTX entered · RLAY entered · BPMC entered · KRON left · SPRY left · CCCC left

# Security Weight before Weight now
1 REVOLUTION MEDICINES INC (RVMD) 19.7% 28.7%
2 EQRX INC (EQRX) 23.5% 15.5%
3 KINNATE BIOPHARMA INC (KNTE) 14.0% 9.7%
4 PMV PHARMACEUTICALS INC (PMVP) 8.4% 8.2%
5 TYRA BIOSCIENCES INC (TYRA) 9.3% 7.7%
6 ARVINAS INC (ARVN) 6.2% 5.5%
7 MIRATI THERAPEUTICS INC (MRTX) 0.0% 4.1% Entered the top 10
8 RELAY THERAPEUTICS INC (RLAY) 0.0% 4.1% Entered the top 10
9 CULLINAN ONCOLOGY INC (CGEM) 5.0% 3.6%
10 BLUEPRINT MEDICINES CORP (BPMC) 0.0% 3.4% Entered the top 10
— KRONOS BIO INC (KRON) 5.2% 3.0% Left the top 10
— SILVERBACK THERAPEUTICS INC (SPRY) 3.4% 1.9% Left the top 10
— C4 THERAPEUTICS INC (CCCC) 3.2% 2.6% Left the top 10

Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).